OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Inflammation at the crossroads of COVID-19, cognitive deficits and depression
Natalia M. Lyra e Silva, Fernanda G. Q. Barros‐Aragão, Fernanda G. De Felice, et al.
Neuropharmacology (2022) Vol. 209, pp. 109023-109023
Open Access | Times Cited: 79
Natalia M. Lyra e Silva, Fernanda G. Q. Barros‐Aragão, Fernanda G. De Felice, et al.
Neuropharmacology (2022) Vol. 209, pp. 109023-109023
Open Access | Times Cited: 79
Showing 1-25 of 79 citing articles:
Prevalence and determinants of post-acute sequelae after SARS-CoV-2 infection (Long COVID) among adults in Mexico during 2022: a retrospective analysis of nationally representative data
Omar Yaxmehen Bello‐Chavolla, Carlos A. Fermín‐Martínez, Daniel Ramírez‐García, et al.
The Lancet Regional Health - Americas (2024) Vol. 30, pp. 100688-100688
Open Access | Times Cited: 24
Omar Yaxmehen Bello‐Chavolla, Carlos A. Fermín‐Martínez, Daniel Ramírez‐García, et al.
The Lancet Regional Health - Americas (2024) Vol. 30, pp. 100688-100688
Open Access | Times Cited: 24
Effect of Ultra-Micronized Palmitoylethanolamide and Luteolin on Olfaction and Memory in Patients with Long COVID: Results of a Longitudinal Study
Pietro De Luca, Angelo Camaioni, Pasquale Marra, et al.
Cells (2022) Vol. 11, Iss. 16, pp. 2552-2552
Open Access | Times Cited: 59
Pietro De Luca, Angelo Camaioni, Pasquale Marra, et al.
Cells (2022) Vol. 11, Iss. 16, pp. 2552-2552
Open Access | Times Cited: 59
Is depression the missing link between inflammatory mediators and cancer?
Barbara Polityńska, Olga Pokorska, Anna M. Wojtukiewicz, et al.
Pharmacology & Therapeutics (2022) Vol. 240, pp. 108293-108293
Closed Access | Times Cited: 45
Barbara Polityńska, Olga Pokorska, Anna M. Wojtukiewicz, et al.
Pharmacology & Therapeutics (2022) Vol. 240, pp. 108293-108293
Closed Access | Times Cited: 45
Neurological manifestations of SARS-CoV-2: complexity, mechanism and associated disorders
Kritika Tyagi, Prachi Rai, Anuj Gautam, et al.
European journal of medical research (2023) Vol. 28, Iss. 1
Open Access | Times Cited: 30
Kritika Tyagi, Prachi Rai, Anuj Gautam, et al.
European journal of medical research (2023) Vol. 28, Iss. 1
Open Access | Times Cited: 30
Cognitive impairment in long-COVID and its association with persistent dysregulation in inflammatory markers
Rodolfo Furlan Damiano, Cristiana Castanho de Almeida Rocca, Antônio de Pádua Serafim, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 25
Rodolfo Furlan Damiano, Cristiana Castanho de Almeida Rocca, Antônio de Pádua Serafim, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 25
Exploring the mechanism of Radix Bupleuri in the treatment of depression combined with SARS-CoV-2 infection through bioinformatics, network pharmacology, molecular docking, and molecular dynamic simulation
Zexing Chen, Xinhua Wang, Wanyi Huang
Metabolic Brain Disease (2025) Vol. 40, Iss. 1
Closed Access | Times Cited: 1
Zexing Chen, Xinhua Wang, Wanyi Huang
Metabolic Brain Disease (2025) Vol. 40, Iss. 1
Closed Access | Times Cited: 1
Prevalence and severity of anxiety, stress, and depression in long COVID among adults in Barcelona
Brenda Biaani León-Gómez, Meritxell Carmona-Cervelló, Rosalía Dacosta‐Aguayo, et al.
BJGP Open (2025), pp. BJGPO.2024.0098-BJGPO.2024.0098
Open Access | Times Cited: 1
Brenda Biaani León-Gómez, Meritxell Carmona-Cervelló, Rosalía Dacosta‐Aguayo, et al.
BJGP Open (2025), pp. BJGPO.2024.0098-BJGPO.2024.0098
Open Access | Times Cited: 1
Sleep and memory complaints in long COVID: an insight into clustered psychological phenotypes
Ricardo Titze‐de‐Almeida, Pedro Lacerda, Edson Pereira de Oliveira, et al.
PeerJ (2024) Vol. 12, pp. e16669-e16669
Open Access | Times Cited: 7
Ricardo Titze‐de‐Almeida, Pedro Lacerda, Edson Pereira de Oliveira, et al.
PeerJ (2024) Vol. 12, pp. e16669-e16669
Open Access | Times Cited: 7
Therapeutic Exercise Interventions through Telerehabilitation in Patients with Post COVID-19 Symptoms: A Systematic Review
Carlos Bernal‐Utrera, Ginés Montero-Almagro, Ernesto Anarte‐Lazo, et al.
Journal of Clinical Medicine (2022) Vol. 11, Iss. 24, pp. 7521-7521
Open Access | Times Cited: 28
Carlos Bernal‐Utrera, Ginés Montero-Almagro, Ernesto Anarte‐Lazo, et al.
Journal of Clinical Medicine (2022) Vol. 11, Iss. 24, pp. 7521-7521
Open Access | Times Cited: 28
Multi-target drugs for the treatment of cognitive impairment and fatigue in post-COVID syndrome: focus on Ginkgo biloba and Rhodiola rosea
Juliane K. Mueller, Walter E. Müller
Journal of Neural Transmission (2024) Vol. 131, Iss. 3, pp. 203-212
Open Access | Times Cited: 6
Juliane K. Mueller, Walter E. Müller
Journal of Neural Transmission (2024) Vol. 131, Iss. 3, pp. 203-212
Open Access | Times Cited: 6
Unraveling the Role of the Blood-Brain Barrier in the Pathophysiology of Depression: Recent Advances and Future Perspectives
Shamili Mariya Varghese, Shashikant Patel, Amritasree Nandan, et al.
Molecular Neurobiology (2024) Vol. 61, Iss. 12, pp. 10398-10447
Closed Access | Times Cited: 6
Shamili Mariya Varghese, Shashikant Patel, Amritasree Nandan, et al.
Molecular Neurobiology (2024) Vol. 61, Iss. 12, pp. 10398-10447
Closed Access | Times Cited: 6
Cognitive function and quantitative electroencephalogram analysis in subjects recovered from COVID-19 infection
Manal M. Gaber, Hanan Hosny, Mona Hussein, et al.
BMC Neurology (2024) Vol. 24, Iss. 1
Open Access | Times Cited: 5
Manal M. Gaber, Hanan Hosny, Mona Hussein, et al.
BMC Neurology (2024) Vol. 24, Iss. 1
Open Access | Times Cited: 5
Co-ultraPEALut in Subjective Cognitive Impairment Following SARS-CoV-2 Infection: An Exploratory Retrospective Study
Valentina Cenacchi, Giovanni Furlanis, Alina Menichelli, et al.
Brain Sciences (2024) Vol. 14, Iss. 3, pp. 293-293
Open Access | Times Cited: 5
Valentina Cenacchi, Giovanni Furlanis, Alina Menichelli, et al.
Brain Sciences (2024) Vol. 14, Iss. 3, pp. 293-293
Open Access | Times Cited: 5
Highlighting the Neuropsychological Consequences of COVID-19: Evidence From a Narrative Review
Kalliopi Megari, Evanthia Thomaidou, Electra Chatzidimitriou
INQUIRY The Journal of Health Care Organization Provision and Financing (2024) Vol. 61
Open Access | Times Cited: 5
Kalliopi Megari, Evanthia Thomaidou, Electra Chatzidimitriou
INQUIRY The Journal of Health Care Organization Provision and Financing (2024) Vol. 61
Open Access | Times Cited: 5
Acute TNFα levels predict cognitive impairment 6–9 months after COVID-19 infection
Anthony Nuber‐Champier, Alexandre Cionca, Gautier Bréville, et al.
Psychoneuroendocrinology (2023) Vol. 153, pp. 106104-106104
Open Access | Times Cited: 12
Anthony Nuber‐Champier, Alexandre Cionca, Gautier Bréville, et al.
Psychoneuroendocrinology (2023) Vol. 153, pp. 106104-106104
Open Access | Times Cited: 12
Associations of hospital-treated infections with subsequent dementia: nationwide 30-year analysis
Leah S. Richmond‐Rakerd, Monica T. Iyer, Stephanie D’Souza, et al.
Nature Aging (2024) Vol. 4, Iss. 6, pp. 783-790
Closed Access | Times Cited: 4
Leah S. Richmond‐Rakerd, Monica T. Iyer, Stephanie D’Souza, et al.
Nature Aging (2024) Vol. 4, Iss. 6, pp. 783-790
Closed Access | Times Cited: 4
Association of pre-existing depression and anxiety with Omicron variant infection
Huazhen Yang, Lei Yang, Wenwen Chen, et al.
Molecular Psychiatry (2024) Vol. 29, Iss. 11, pp. 3422-3430
Closed Access | Times Cited: 4
Huazhen Yang, Lei Yang, Wenwen Chen, et al.
Molecular Psychiatry (2024) Vol. 29, Iss. 11, pp. 3422-3430
Closed Access | Times Cited: 4
Exploring the causal effects of depression and antidepressants on COVID-19
Li Fu, Ancha Baranova, Hongbao Cao, et al.
Journal of Affective Disorders (2024) Vol. 359, pp. 350-355
Closed Access | Times Cited: 4
Li Fu, Ancha Baranova, Hongbao Cao, et al.
Journal of Affective Disorders (2024) Vol. 359, pp. 350-355
Closed Access | Times Cited: 4
Changes in neuroinflammatory biomarkers correlate with disease severity and neuroimaging alterations in patients with COVID-19 neurological complications
Fernanda G. Q. Barros‐Aragão, Talita P. Pinto, Victor Corasolla Carregari, et al.
Brain Behavior & Immunity - Health (2024) Vol. 39, pp. 100805-100805
Open Access | Times Cited: 4
Fernanda G. Q. Barros‐Aragão, Talita P. Pinto, Victor Corasolla Carregari, et al.
Brain Behavior & Immunity - Health (2024) Vol. 39, pp. 100805-100805
Open Access | Times Cited: 4
Neuroinflammation: Unraveling acute and Long COVID symptoms
Sonia Villapol
Elsevier eBooks (2025), pp. 437-457
Closed Access
Sonia Villapol
Elsevier eBooks (2025), pp. 437-457
Closed Access
Efeitos da pandemia na saúde mental de cuidadores de pacientes com demência: revisão de literatura
Viviane Siqueira Magalhães Rebelo, Yara Ayami Matos Abe, Ana Paula da Silva Farias Tietz, et al.
Contribuciones a las Ciencias Sociales (2025) Vol. 18, Iss. 1, pp. e14660-e14660
Open Access
Viviane Siqueira Magalhães Rebelo, Yara Ayami Matos Abe, Ana Paula da Silva Farias Tietz, et al.
Contribuciones a las Ciencias Sociales (2025) Vol. 18, Iss. 1, pp. e14660-e14660
Open Access
COVID-19 related complications
Muhamed Adilović
Progress in molecular biology and translational science (2025)
Closed Access
Muhamed Adilović
Progress in molecular biology and translational science (2025)
Closed Access
Cognitive Sequelae of COVID ‐19: Mechanistic Insights and Therapeutic Approaches
Yuhao Chen, Jing‐Shiun Jan, Chih‐Hao Yang, et al.
CNS Neuroscience & Therapeutics (2025) Vol. 31, Iss. 3
Open Access
Yuhao Chen, Jing‐Shiun Jan, Chih‐Hao Yang, et al.
CNS Neuroscience & Therapeutics (2025) Vol. 31, Iss. 3
Open Access
SARS-CoV-2 post-acute sequelae linked to inflammation via extracellular vesicles
Sara Bachiller, Joana Vitallé, Lluís Camprubí-Ferrer, et al.
Frontiers in Immunology (2025) Vol. 16
Open Access
Sara Bachiller, Joana Vitallé, Lluís Camprubí-Ferrer, et al.
Frontiers in Immunology (2025) Vol. 16
Open Access
Comparison of cerebrospinal fluid biomarkers in patients with severe COVID-19 neurological outcomes and Alzheimer’s disease
Fernanda G. Q. Barros‐Aragão, Thaís L. Pinheiro, Talita P. Pinto, et al.
Brain Behavior & Immunity - Health (2025), pp. 101007-101007
Open Access
Fernanda G. Q. Barros‐Aragão, Thaís L. Pinheiro, Talita P. Pinto, et al.
Brain Behavior & Immunity - Health (2025), pp. 101007-101007
Open Access
